한글목차

신경변성질환 치료제 시장은 2023-2028년 212억 9,000만 달러로 예측되며, 예측 기간 동안 8.51%의 CAGR로 성장할 것으로 예상됩니다.

본 보고서는 신경변성질환 치료제 시장의 전반적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 포함한 벤더 분석 등을 정리하여 전해드립니다.

현재 시장 시나리오, 최신 동향 및 촉진요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 이 시장은 강력한 신약 개발 파이프라인, 신경변성질환에 대한 높은 연구 자금, 고감도 진단 양식의 가용성에 의해 주도되고 있습니다.

이 보고서는 향후 몇 년간 신경변성질환 치료제 시장 성장을 견인할 주요 요인 중 하나로 고령화 인구의 증가를 꼽았습니다. 또한, 신경변성질환의 유전적 기반과 분자적 병태가 밝혀지고 경제적 부담이 큰 것도 시장의 큰 수요로 이어질 것으로 보입니다.

목차

제1장 주요 요약

• 시장 개요

제2장 시장 상황

• 시장 생태계
• 시장 특징
• 밸류체인 분석

제3장 시장 규모 평가

• 시장 정의
• 시장 부문 분석
• 시장 규모 2023
• 시장 전망 2023-2028

제4장 시장 규모 실적

• 세계 신경변성질환 치료제 시장 2018-2022
• 적응증별 부문 분석 2018-2022
• 지역별 부문 분석 2018-2022
• 국가별 부문 분석 2018-2022

제5장 Five Forces 분석

• Five Forces 요약
• 구매자의 교섭력
• 공급 기업의 교섭력
• 신규 참여업체의 위협
• 대체품의 위협
• 경쟁의 위협
• 시장 상황

제6장 시장 세분화 : 적응증별

• 시장 세분화
• 비교 : 적응증별
• 다발성 경화증 : 시장 규모와 예측 2023-2028
• 알츠하이머병 : 시장 규모와 예측 2023-2028
• 파킨슨병 : 시장 규모와 예측 2023-2028
• 헌팅턴병 : 시장 규모와 예측 2023-2028
• 기타 : 시장 규모와 예측 2023-2028
• 시장 기회 : 적응증별

제7장 고객 상황

• 고객 상황 개요

제8장 지역별 상황

• 지역별 세분화
• 지역별 비교
• 북미 : 시장 규모와 예측 2023-2028
• 유럽 : 시장 규모와 예측 2023-2028
• 아시아 : 시장 규모와 예측 2023-2028
• 세계 기타 지역 : 시장 규모와 예측 2023-2028
• 미국 : 시장 규모와 예측 2023-2028
• 캐나다 : 시장 규모와 예측 2023-2028
• 영국 : 시장 규모와 예측 2023-2028
• 독일 : 시장 규모와 예측 2023-2028
• 일본 : 시장 규모와 예측 2023-2028
• 중국 : 시장 규모와 예측 2023-2028
• 시장 기회 : 지역 상황별

제9장 촉진요인, 과제, 기회, 억제요인

• 시장 성장 촉진요인
• 시장 과제
• 성장 촉진요인과 과제의 영향
• 시장 기회·억제요인

제10장 경쟁 상황

• 개요
• 경쟁 상황
• 혼란 상황
• 업계 리스크

제11장 경쟁 분석

• 기업 개요
• 기업의 시장 포지셔닝
• AB Science SA
• AbbVie Inc.
• Acadia Pharmaceuticals Inc.
• Biogen Inc.
• F. Hoffmann La Roche Ltd.
• H Lundbeck AS
• Mitsubishi Chemical Corp.
• Novartis AG
• Sanofi SA
• Teva Pharmaceutical Industries Ltd.

제12장 부록

영문목차

The neurodegenerative diseases therapeutics market is forecasted to grow by USD 21290 mn during 2023-2028, accelerating at a CAGR of 8.51% during the forecast period. The report on the neurodegenerative diseases therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by strong drug development pipeline, high research funding on neurodegenerative diseases, and availability of highly sensitive diagnostic modalities.

Technavio's neurodegenerative diseases therapeutics market is segmented as below:

By Indication

• Multiple sclerosis
• Alzheimers disease
• Parkinsons disease
• Huntingtons disease
• Others

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the increase in aging population as one of the prime reasons driving the neurodegenerative diseases therapeutics market growth during the next few years. Also, improved understanding of genetic basis and molecular pathology of neurodegenerative diseases and high economic burden will lead to sizable demand in the market.

The report on the neurodegenerative diseases therapeutics market covers the following areas:

• Neurodegenerative diseases therapeutics market sizing
• Neurodegenerative diseases therapeutics market forecast
• Neurodegenerative diseases therapeutics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading neurodegenerative diseases therapeutics market vendors that include AB Science SA, AbbVie Inc., Acadia Pharmaceuticals Inc., Biogen Inc., F. Hoffmann La Roche Ltd., H Lundbeck AS, Mitsubishi Chemical Corp., Novartis AG, Sanofi SA, and Teva Pharmaceutical Industries Ltd.. Also, the neurodegenerative diseases therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. IT presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by Indication
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 2.2 Market characteristics
  • Market characteristics analysis
• 2.3 Value chain analysis
  • Value Chain Analysis

3 Market Sizing

• 3.1 Market definition
  • Offerings of companies included in the market definition
• 3.2 Market segment analysis
  • Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
  • Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global Neurodegenerative Diseases Therapeutics Market 2018 - 2022
  • Historic Market Size - Data Table on Global Neurodegenerative Diseases Therapeutics Market 2018 - 2022 ($ million)
• 4.2 Indication segment analysis 2018 - 2022
  • Historic Market Size - Indication Segment 2018 - 2022 ($ million)
• 4.3 Geography segment analysis 2018 - 2022
  • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 4.4 Country segment analysis 2018 - 2022
  • Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
  • Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
  • Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Indication

• 6.1 Market segments
  • Chart on Indication - Market share 2023-2028 (%)
  • Data Table on Indication - Market share 2023-2028 (%)
• 6.2 Comparison by Indication
  • Chart on Comparison by Indication
  • Data Table on Comparison by Indication
• 6.3 Multiple sclerosis - Market size and forecast 2023-2028
  • Chart on Multiple sclerosis - Market size and forecast 2023-2028 ($ million)
  • Data Table on Multiple sclerosis - Market size and forecast 2023-2028 ($ million)
  • Chart on Multiple sclerosis - Year-over-year growth 2023-2028 (%)
  • Data Table on Multiple sclerosis - Year-over-year growth 2023-2028 (%)
• 6.4 Alzheimers disease - Market size and forecast 2023-2028
  • Chart on Alzheimers disease - Market size and forecast 2023-2028 ($ million)
  • Data Table on Alzheimers disease - Market size and forecast 2023-2028 ($ million)
  • Chart on Alzheimers disease - Year-over-year growth 2023-2028 (%)
  • Data Table on Alzheimers disease - Year-over-year growth 2023-2028 (%)
• 6.5 Parkinsons disease - Market size and forecast 2023-2028
  • Chart on Parkinsons disease - Market size and forecast 2023-2028 ($ million)
  • Data Table on Parkinsons disease - Market size and forecast 2023-2028 ($ million)
  • Chart on Parkinsons disease - Year-over-year growth 2023-2028 (%)
  • Data Table on Parkinsons disease - Year-over-year growth 2023-2028 (%)
• 6.6 Huntingtons disease - Market size and forecast 2023-2028
  • Chart on Huntingtons disease - Market size and forecast 2023-2028 ($ million)
  • Data Table on Huntingtons disease - Market size and forecast 2023-2028 ($ million)
  • Chart on Huntingtons disease - Year-over-year growth 2023-2028 (%)
  • Data Table on Huntingtons disease - Year-over-year growth 2023-2028 (%)
• 6.7 Others - Market size and forecast 2023-2028
  • Chart on Others - Market size and forecast 2023-2028 ($ million)
  • Data Table on Others - Market size and forecast 2023-2028 ($ million)
  • Chart on Others - Year-over-year growth 2023-2028 (%)
  • Data Table on Others - Year-over-year growth 2023-2028 (%)
• 6.8 Market opportunity by Indication
  • Market opportunity by Indication ($ million)
  • Data Table on Market opportunity by Indication ($ million)

7 Customer Landscape

• 7.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

8 Geographic Landscape

• 8.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 8.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 8.3 North America - Market size and forecast 2023-2028
  • Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Chart on North America - Year-over-year growth 2023-2028 (%)
  • Data Table on North America - Year-over-year growth 2023-2028 (%)
• 8.4 Europe - Market size and forecast 2023-2028
  • Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 8.5 Asia - Market size and forecast 2023-2028
  • Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 8.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 8.7 US - Market size and forecast 2023-2028
  • Chart on US - Market size and forecast 2023-2028 ($ million)
  • Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Chart on US - Year-over-year growth 2023-2028 (%)
  • Data Table on US - Year-over-year growth 2023-2028 (%)
• 8.8 Canada - Market size and forecast 2023-2028
  • Chart on Canada - Market size and forecast 2023-2028 ($ million)
  • Data Table on Canada - Market size and forecast 2023-2028 ($ million)
  • Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Data Table on Canada - Year-over-year growth 2023-2028 (%)
• 8.9 UK - Market size and forecast 2023-2028
  • Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Chart on UK - Year-over-year growth 2023-2028 (%)
  • Data Table on UK - Year-over-year growth 2023-2028 (%)
• 8.10 Germany - Market size and forecast 2023-2028
  • Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 8.11 Japan - Market size and forecast 2023-2028
  • Chart on Japan - Market size and forecast 2023-2028 ($ million)
  • Data Table on Japan - Market size and forecast 2023-2028 ($ million)
  • Chart on Japan - Year-over-year growth 2023-2028 (%)
  • Data Table on Japan - Year-over-year growth 2023-2028 (%)
• 8.12 China - Market size and forecast 2023-2028
  • Chart on China - Market size and forecast 2023-2028 ($ million)
  • Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Chart on China - Year-over-year growth 2023-2028 (%)
  • Data Table on China - Year-over-year growth 2023-2028 (%)
• 8.13 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ million)
  • Data Tables on Market opportunity By Geographical Landscape ($ million)

9 Drivers, Challenges, and Opportunity/Restraints

• 9.1 Market drivers
• 9.2 Market challenges
• 9.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028
• 9.4 Market opportunities/restraints

10 Competitive Landscape

• 10.1 Overview
• 10.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 10.3 Landscape disruption
  • Overview on factors of disruption
• 10.4 Industry risks
  • Impact of key risks on business

11 Competitive Analysis

• 11.1 Companies profiled
  • Companies covered
• 11.2 Market positioning of companies
  • Matrix on companies position and classification
• 11.3 AB Science SA
  • AB Science SA - Overview
  • AB Science SA - Product / Service
  • AB Science SA - Key offerings
• 11.4 AbbVie Inc.
  • AbbVie Inc. - Overview
  • AbbVie Inc. - Product / Service
  • AbbVie Inc. - Key news
  • AbbVie Inc. - Key offerings
• 11.5 Acadia Pharmaceuticals Inc.
  • Acadia Pharmaceuticals Inc. - Overview
  • Acadia Pharmaceuticals Inc. - Product / Service
  • Acadia Pharmaceuticals Inc. - Key offerings
• 11.6 Biogen Inc.
  • Biogen Inc. - Overview
  • Biogen Inc. - Product / Service
  • Biogen Inc. - Key news
  • Biogen Inc. - Key offerings
• 11.7 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus
• 11.8 H Lundbeck AS
  • H Lundbeck AS - Overview
  • H Lundbeck AS - Product / Service
  • H Lundbeck AS - Key offerings
• 11.9 Mitsubishi Chemical Corp.
  • Mitsubishi Chemical Corp. - Overview
  • Mitsubishi Chemical Corp. - Business segments
  • Mitsubishi Chemical Corp. - Key offerings
  • Mitsubishi Chemical Corp. - Segment focus
• 11.10 Novartis AG
  • Novartis AG - Overview
  • Novartis AG - Business segments
  • Novartis AG - Key news
  • Novartis AG - Key offerings
  • Novartis AG - Segment focus
• 11.11 Sanofi SA
  • Sanofi SA - Overview
  • Sanofi SA - Business segments
  • Sanofi SA - Key news
  • Sanofi SA - Key offerings
  • Sanofi SA - Segment focus
• 11.12 Teva Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd. - Overview
  • Teva Pharmaceutical Industries Ltd. - Business segments
  • Teva Pharmaceutical Industries Ltd. - Key news
  • Teva Pharmaceutical Industries Ltd. - Key offerings
  • Teva Pharmaceutical Industries Ltd. - Segment focus

12 Appendix

• 12.1 Scope of the report
• 12.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 12.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 12.4 Research methodology
  • Research methodology
• 12.5 Data procurement
  • Information sources
• 12.6 Data validation
  • Data validation
• 12.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 12.8 Data synthesis
  • Data synthesis
• 12.9 360 degree market analysis
  • 360 degree market analysis
• 12.10 List of abbreviations
  • List of abbreviations